| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.0M | +27.2% | -77.8% |
| R&D Expense | $165.4M | +0.5% | +16.8% |
| SG&A Expense | $175.1M | +22.3% | +23.7% |
| Operating Income | -$339.2M | -10.7% | -23.6% |
| Pre-tax Income | -$290.4M | -82.6% | -23.8% |
| Income Tax | $23.3M | +233.6% | +191.3% |
| Net Income | -$265.9M | -134.2% | -257.0% |
| EPS (Basic) | -$0.38 | -123.5% | -265.2% |
| EPS (Diluted) | -$0.38 | -123.5% | -265.2% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.48B | +19.5% | -25.7% |
| Short-term Investments | $3.05B | -3.1% | -3.3% |
| Current Assets | $4.66B | +3.3% | -13.1% |
| Total Assets | $5.23B | +3.2% | -9.8% |
| Current Liabilities | $152.0M | +13.5% | +7.4% |
| Total Liabilities | $251.1M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$586.5M | — | — |
| Capital Expenditures | $6.9M | — | — |
| Investing Cash Flow | -$855.8M | — | — |
| Financing Cash Flow | $203.0M | — | — |
| Free Cash Flow | -$593.5M | — | — |
| -2.0% |
| Stockholders' Equity | $4.27B | -2.1% | -17.7% |